Pelubiprofen/Eperisone Hydrochloride

培鲁比洛芬/盐酸乙哌立松

Report date: 2022/09/05 16:12:32

Base Information

Drug NamePelubiprofen/Eperisone Hydrochloride
Drug Alias NamePelubiprofen+Eperisone Hydrochloride培鲁比洛芬+盐酸乙哌立松Eperisone Hydrochloride/Pelubiprofen盐酸乙哌立松/培鲁比洛芬Eperisone Hydrochloride+Pelubiprofen +[6] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channelCyclooxygenases
Therapy Area/IndicationsBack Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Eperisone HydrochloridePelubiprofen
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDaewon Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaewon Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsBack Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A